Carbon monoxide diffusing capacity in asthmatic patients with mild airflow limitation

Area of Science:

• Pulmonary Medicine
• Respiratory Physiology

Background:

• Asthma is a chronic respiratory disease characterized by airway inflammation and variable airflow obstruction.
• Accurate measurement of lung function, including diffusing capacity, is crucial for assessing asthma severity and progression.
• Previous studies suggest potential alterations in diffusing capacity in asthma, but findings in mild disease are less clear.

Purpose of the Study:

• To investigate whether carbon monoxide diffusing capacity (DCO) is elevated in asthmatic patients with minimal airflow limitation.
• To determine if factors like hyperinflation, which can affect DCO measurements, are present in mild asthma.
• To explore the relationship between DCO and its components (membrane diffusing capacity and pulmonary capillary blood volume) in mild asthma.

Main Methods:

• Single-breath method was used to measure DCO and its components (membrane diffusing capacity [Dm] and pulmonary capillary blood volume [Qc]).
• Measurements were normalized for alveolar volume (VA).
• Ten asthmatic subjects with minimal airflow limitation and ten healthy subjects were studied.

Main Results:

• Asthmatic subjects showed higher mean DCO/VA and Qc/VA compared to healthy controls.
• The ratio of Dm/Qc was also elevated in the asthma group.
• In asthmatics, DCO/VA and Qc/VA were negatively correlated with measures of airflow limitation (FEF50 and PIFR).

Conclusions:

• Carbon monoxide diffusing capacity (DCO/VA) may be increased in asthmatic patients even with mild airflow limitation.
• This elevation in DCO/VA appears to be primarily driven by an increase in pulmonary capillary blood volume (Qc/VA).
• These findings suggest a potential vascular remodeling or recruitment contributing to altered lung function in early-stage asthma.